- ISIN
- US7611521078
- CUSIP
- 761152107
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- IPO Date
- Jun 2, 1995
Highlights
- EPS (TTM)
- $13.78
- PE Ratio
- 13.68
- PEG Ratio
- 0.42
- Total Revenue (TTM)
- $5.54B
- Gross Profit (TTM)
- $3.42B
- EBITDA (TTM)
- $2.10B
- Year Range
- $180.27 - $293.81
- Target Price
- $291.25
- ROA (TTM)
- 17.30%
- ROE (TTM)
- 23.41%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
RMD Performance Chart
ResMed Inc. (RMD) is down 21.4% since the beginning of the year. At $188 per share, RMD is trading 35.9% below its 52-week high of $294. Investors who bought $1,000 worth of RMD shares 5 years ago would now be looking at an investment worth $809.
Loading charts...
Returns By Period
ResMed Inc. (RMD) has returned -21.35% so far this year and -24.99% over the past 12 months. Over the last ten years, RMD has had an annualized return of 13.30%, just under the S&P 500 Index benchmark’s 13.88%.
ResMed Inc.
- 1D
- -0.10%
- 1M
- -9.42%
- YTD
- -21.35%
- 6M
- -23.20%
- 1Y
- -24.99%
- 3Y*
- -3.40%
- 5Y*
- -4.15%
- 10Y*
- 13.30%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
RMD Monthly Returns History
Based on dividend-adjusted daily data since Jun 2, 1995, RMD's average daily return is +0.11%, while the average monthly return is +2.07%. At this rate, an investment would double in approximately 2.8 years.
Historically, 60% of months were positive and 40% were negative. The best month was Feb 2000 with a return of +73.5%, while the worst month was Feb 1999 at -37.1%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 5 months.
On a daily basis, RMD closed higher 51% of trading days. The best single day was Apr 14, 1999 with a return of +27.4%, while the worst single day was May 3, 2000 at -22.6%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 7.24% | -0.56% | -12.40% | -4.75% | -10.60% | -1.11% | -21.35% | ||||||
| 2025 | 3.28% | -0.90% | -4.14% | 5.69% | 3.69% | 5.40% | 5.40% | 1.16% | -0.28% | -9.81% | 3.87% | -5.85% | 6.26% |
| 2024 | 10.57% | -8.43% | 13.99% | 8.06% | -3.37% | -7.23% | 11.40% | 15.17% | -0.37% | -0.68% | 2.92% | -8.16% | 34.18% |
| 2023 | 9.72% | -6.55% | 2.81% | 10.03% | -12.35% | 3.66% | 1.76% | -28.04% | -7.34% | -4.50% | 12.05% | 9.06% | -16.55% |
| 2022 | -12.24% | 8.13% | -1.72% | -17.54% | 1.96% | 3.03% | 14.74% | -8.39% | -0.74% | 2.47% | 3.12% | -9.59% | -19.47% |
| 2021 | -5.17% | -4.17% | 0.64% | -3.12% | 9.73% | 19.76% | 10.25% | 7.05% | -9.29% | -0.24% | -2.91% | 2.21% | 23.41% |
Benchmark Metrics
ResMed Inc. has an annualized alpha of 20.07%, beta of 0.80, and R2 of 0.14 versus S&P 500 Index. Calculated based on daily prices since June 02, 1995.
- This stock captured 124.89% of S&P 500 Index gains but only 74.95% of its losses - a favorable profile for investors.
- R2 of 0.14 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 20.07%
- Beta
- 0.80
- R²
- 0.14
- Upside Capture
- 124.89%
- Downside Capture
- 74.95%
Return for Risk
Risk / Return Rank
RMD ranks 9 for risk / return — in the bottom 9% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for ResMed Inc. (RMD) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| RMD | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.06 | ||
| Sortino ratioReturn per unit of downside risk | -4.12 | ||
| Omega ratioGain probability vs. loss probability | 0.84 | 1.37 | -0.53 |
| Calmar ratioReturn relative to maximum drawdown | -0.67 | 2.78 | -3.46 |
| Martin ratioReturn relative to average drawdown | -1.45 | 12.44 | -13.89 |
Dividends
Dividend History
ResMed Inc. provided a 1.27% dividend yield over the last twelve months, with an annual payout of $2.40 per share. The company has been increasing its dividends for 13 consecutive years.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $2.40 | $2.26 | $2.02 | $1.84 | $1.72 | $1.62 | $1.56 | $1.52 | $1.44 | $1.36 | $1.26 | $1.16 |
Dividend yield | 1.27% | 0.94% | 0.88% | 1.07% | 0.83% | 0.62% | 0.73% | 0.98% | 1.26% | 1.61% | 2.03% | 2.16% |
Monthly Dividends
The table displays the monthly dividend distributions for ResMed Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.60 | $0.00 | $0.00 | $0.60 | $0.00 | $1.20 | ||||||
| 2025 | $0.00 | $0.53 | $0.00 | $0.00 | $0.53 | $0.00 | $0.00 | $0.60 | $0.00 | $0.00 | $0.60 | $0.00 | $2.26 |
| 2024 | $0.00 | $0.48 | $0.00 | $0.00 | $0.48 | $0.00 | $0.00 | $0.53 | $0.00 | $0.00 | $0.53 | $0.00 | $2.02 |
| 2023 | $0.00 | $0.44 | $0.00 | $0.00 | $0.44 | $0.00 | $0.00 | $0.48 | $0.00 | $0.00 | $0.48 | $0.00 | $1.84 |
| 2022 | $0.00 | $0.42 | $0.00 | $0.00 | $0.42 | $0.00 | $0.00 | $0.44 | $0.00 | $0.00 | $0.44 | $0.00 | $1.72 |
| 2021 | $0.00 | $0.39 | $0.00 | $0.00 | $0.39 | $0.00 | $0.00 | $0.42 | $0.00 | $0.00 | $0.42 | $0.00 | $1.62 |
Dividend Yield & Payout
Dividend Yield
ResMed Inc. has a dividend yield of 1.27%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
ResMed Inc. has a payout ratio of 22.39%, which is below the market average. This means ResMed Inc. returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the ResMed Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the ResMed Inc. was 61.61%, occurring on Apr 8, 1999. Recovery took 200 trading sessions.
The current ResMed Inc. drawdown is 35.35%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
1999 bear market1999 | -61.61%Apr 1999 | 2mo 12d | 9mo 18d | 12moJan 1999 - Jan 2000 |
Dot-com crash2000–2002 | -60.00%Jun 2002 | 6mo 4d | 2y 10mo | 3y 4moDec 2001 - Apr 2005 |
2023 bear market2023 | -53.99%Oct 2023 | 2y 1mo | 1y 9mo | 3y 11moSep 2021 - Aug 2025 |
Financial crisis2007–2009 | -45.02%Oct 2008 | 1y 8mo | 1y 3mo | 3y 1dFeb 2007 - Feb 2010 |
Dot-com crash2000–2002 | -44.48%May 2000 | 2mo 4d | 7mo | 9mo 4dMar 2000 - Dec 2000 |
Drawdown Indicators
| RMD | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -61.61% | -56.78% | -4.83% |
Max Drawdown (1Y)Largest decline over 1 year | -37.28% | -9.10% | -28.18% |
Max Drawdown (3Y)Largest decline over 3 years | -40.09% | -18.90% | -21.19% |
Max Drawdown (5Y)Largest decline over 5 years | -53.99% | -25.43% | -28.56% |
Max Drawdown (10Y)Largest decline over 10 years | -53.99% | -33.92% | -20.07% |
Current DrawdownCurrent decline from peak | -35.35% | -1.80% | -33.55% |
Average DrawdownAverage peak-to-trough decline | -16.01% | -10.71% | -5.30% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 17.21% | 2.03% | +15.18% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of ResMed Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how ResMed Inc. is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for RMD, comparing it with other companies in the Medical Instruments & Supplies industry. Currently, RMD has a P/E ratio of 13.7. This P/E ratio is considered low compared to industry peers, which may suggest that the stock is undervalued or that the company has weaker growth prospects.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for RMD compared to other companies in the Medical Instruments & Supplies industry. RMD currently has a PEG ratio of 0.4. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for RMD relative to other companies in the Medical Instruments & Supplies industry. Currently, RMD has a P/S ratio of 3.8. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with RMD
Add ResMed Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with RMD